| dc.contributor.author | Ozaras, Resat | |
| dc.contributor.author | Ozaras, Nihal | |
| dc.contributor.author | Demirel, Aslihan | |
| dc.date.accessioned | 2019-08-13T12:10:23Z | |
| dc.date.accessioned | 2019-08-13T15:55:32Z | |
| dc.date.available | 2019-08-13T12:10:23Z | |
| dc.date.available | 2019-08-13T15:55:32Z | |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 1542-3565 | |
| dc.identifier.issn | 1542-7714 | |
| dc.identifier.uri | https://dx.doi.org/10.1016/j.cgh.2018.07.028 | |
| dc.identifier.uri | http://hdl.handle.net/11446/2056 | |
| dc.description | WOS: 000453252900040 | en_US |
| dc.description | PubMed ID: 30558892 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | ELSEVIER SCIENCE INC | en_US |
| dc.identifier.doi | 10.1016/j.cgh.2018.07.028 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | The Risk of Hepatitis B Virus Reactivation in HBsAg-Negative and Anti-HBc-Positive Patients Receiving Tumor Necrosis Factor Antagonists | en_US |
| dc.type | letter | en_US |
| dc.relation.journal | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | en_US |
| dc.department | DBÜ | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.volume | 17 | en_US |
| dc.identifier.startpage | 210 | en_US |
| dc.identifier.endpage | 210 | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.department-temp | [Ozaras, Resat] Medilife Hosp, Infect Dept, Istanbul, Turkey -- [Ozaras, Nihal] Avrasya Hosp, Phys Med & Rehabil Dept, Istanbul, Turkey -- [Demirel, Aslihan] Bilim Univ, Infect Dept, Istanbul, Turkey | en_US |
